newsfilter
← Latest News
PR Newswire·

IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies

IntraGel Therapeutics, developer of next generation long-acting injectables, today announced an equity investment agreement and a strategic Option...